Multhoff et al. (2020) conducted a trial of autologous NK cells stimulated ex vivo with low-dose IL-2 and membrane-bound Hsp70 (mHsp70) peptides in patients with unresectable NSCLC with expression of mHsp70 after radiochemotherapy [60]. This evidence concerns the gene IL2 and non-small cell lung carcinoma.